Epstein-Barr virus (EBV) DNA sequences were detected in four established monoblast or early monocytic cell lines (CM-S, ROV-S, CV-S and AD-S) obtained from bone marrow of children suffering from maturation defects of haematopoiesis. EBV is present in these cells in a latent state. The viral DNA in these cell lines was analysed by Southern blot hybridization, using a set of cloned EBV DNA fragments from the EBV strain B95-8 as probes. A common spectrum of highly related but distinguishable EBV DNA restriction enzyme sequences was found, suggesting some genomic diversity. Propagation of the cells in long-term culture revealed a gradual decrease of EBV copies per cell in all lines with some minor changes in the restriction pattern of the EBV DNA. These findings demonstrate that human precursor monocyte cells may be susceptible to infection by EBV.
INTRODUCTfON
The Epstein-Barr virus (EBV), aetiological agent of infectious mononucleosis (see review by Epstein & Achong, 1979) , infects human B lymphocytes which then convert to continuously proliferating lymphoblastoid ceils. EBV DNA usually persists in cells of these lines in multiple copies in a latent state and spontaneous induction of viral antigens and particle synthesis may occur at a low rate. Once believed to have a restricted tropism for mature B cells (Rosen et al., 1977) , EBV has also been found to infect cells much earlier in the B cell lineage (Katamine et al., 1984; Tosato et al., 1986) , even before the immunoglobulin (Ig) gene rearrangement (Katamine et al., 1984) . Serological markers of EBV have sporadically been detected also in continuous haematopoietic cell lines distinct from the common B cell lymphoblastoid lines (Dolyniuk et al., 1976; Einhorn & H6st, 1984; Fingeroth et al., 1984; Frade et al., 1985) , suggesting the possibility of a wider spectrum of EBV targets in vivo. Furthermore, EBV DNA has commonly been detected in epithelial cells of nasopharyngeal carcinoma (NPC) biopsies (Nonoyama & Pagano, 1973) , and by in situ hybridization in epithelial cells of the oropharynx from patients with infectious mononucleosis (Lemon et al., 1977) . EBV was also found to infect primary explant cultures of human ectocervix epithelial cells in vitro (Sixbey et al., 1983) . Immortalization of human T lymphocytes after transfection of EBV DNA has been recently reported (Stevenson et al., 1986) . T cell lymphomas containing EBV DNA have been described in patients with chronic EBV infections (Jones et al., 1988) . The association of the EBV genome with permanently~' growing cells of non-B cell lineage, such as fibroblasts or epithelial cells (Miller et al., 1981 ; Staczek et al., 1981) , clearly demonstrates that once the virus is introduced into non-lymphoid cells, there is no inherent restraint to its expression. 
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Preliminary serological studies carried out in our laboratories (Rocchi et al., 1984) suggested the presence of EBV in an established monocyte-macrophage precursor cell line (CM-S) (Monaco et al., 1982) obtained from the bone marrow of a child with congenital hypoplastic (Diamond-Blackfan) anaemia, a rare non-neoplastic childhood defect in bone marrow erythropoiesis. Here we report that EBV DNA sequences are present in the CM-S line and in three other monocytic lines from children suffering with maturation defects of myelopoiesis.
METHODS
Cell culture lines. Four autonomous cell lines were established from bone marrow blood samples obtained from young patients affected by a variety of disorders: a 3 year-old male with congenital hypoplastic (DiamondBlackfan) anaemia (line CM-S), a 7 month-old male with cyclic neutropenia (line AD-S), a 1 year-old female also with cyclic neutropenia (line CV-S) and a 6 month-old male with cyclic dysmyelopoiesis associated with pancreatic insufficiency (Shwachman-Diamond syndrome) (line ROV-S). The establishment, growth properties, ultrastructural and in vitro differentiation characteristics of the four lines have been presented in detail (Monaco et al., 1982; Ranelletti et al., 1983; Bertolini et al., 1984; Sambuy et al., 1985; Revoltella et al., 1986; Romitti et al., 1986) . Tables 1 and 2 summarize the observed i mmunotype and other various markers of the lines, Fig. 1 illustrates the typical appearance of the cell lines. Briefly, they can be characterized as monocyte-macrophage progenitor cell lines in that the cells grow in suspension in an undifferentiated form, but they can be stimulated to differentiate and resemble macrophage cells in the presence of appropriate chemicals, such as the tumour promoter 12-0-tetradeeanoyl phorbol 13-acetate (TPA) (Monaco et al., 1982; Ranelletti et al., 1983 Ranelletti et al., , 1986 Bertolini et al., 1984; Sambuy et al., 1985; Revoltella et al., 1986; Romitti et al., 1986) . Criteria for monoeyte-macrophage differentiation in response to TPA included adherence to the culture vessel, loss of replicative capacity, positive non-specific esterase activity, production of colony-stimulating factors for granulocyte and macrophage precursors, interleukin 1 (IL-1) and lysozyme, expression of histocompatibility class II (HLA DR and DQ) antigens and monocyte-restricted membrane antigens, Fc and C3b rosette formation, immunophagocytosis and phagocytic properties. Both untreated and TPA-treated cells of all lines constantly failed to express surface or intracytoplasmic Ig of any class and Ig heavy and light chain mRNA species, B cell-and T cell-restricted surface antigens.
Three lines (CM-S, AD-S and CV-S) retained a diploid karyotype for several passages in culture 0asting months) during which time they consistently failed to give rise to colonies in agar or tumours when inoculated into athymic mice. On prolonged culture, however, these cells gradually lost their differentiation capacity in vitro, acquired non-random chromosome abnormalities and altered growth properties, eventually becoming capable of spontaneous colony formation in agar and of tumour formation in athymic mice (CM-S from about passage 200, AD-S from passage 96 and CV-S from passage 22) (Sambuy et al., 1985; Revoltella et al., 1986; Romitti et al., 1986) . The majority of both early and late passage ROV-S cells mimic abnormal monoblasts; most of these cells express some enzyme activities commonly associated with macrophages, but they do not respond to the inducing agents active on CM-S, AD-S and CV-S ceils and do not differentiate in response to TPA/n vitro. ROV-S cell line at passage 10 was able to induce tumours in athymic mice .
Stabilized suspension cell cultures were maintained in Dulbecco's modified Eagle's medium (DMEM) (Gibco) supplemented with 20% foetal calf serum (FCS) (Flow Laboratories), 10% trypticase soy broth (BBL) and antibiotics in plastic flasks (Falcon) which were kept tightly closed at 37 °C. These cells were split 1 : 3 every third day with fresh medium. Seed samples of cells taken at different time intervals from the beginning of the cultures were cryopreserved.
Other cell lines, A number of EBV genome-positive and genome-negative B cell lymphoblastoid lines were used as controls in some experiments. These lines included Raji, Ramos-nut, P3JHR-1, originally obtained from Dr G. Klein, Stockholm, VLL and several other B cell lymphoblastoid lines obtained in culture by infection with B95-8 EBV (Ragona et al., 1986) . Immunofluorescence (1F) . The presence of the EBV nuclear antigen (EBNA) was tested by anti-complement IF (Reedman & Klein, 1973) . Viral capsid antigens (VCA) and early viral antigens (EA) were assigned by indirect IF (Henle & Henle, 1966) . The following panel of human sera with or without EBV antibody was used: healthy EBV seropositive (8) and seronegative (8) donors, chronic infectious mononucleosis (8), NPC (5), thymic carcinoma (3), Hodgkin's and non-Hodgkin's lymphoma (7), acquired immune deficiency syndrome (7), American Burkitt's lymphoma, seropositive (6) and seronegative (6), pneumonia (5) and thrombocytopenia (5).
Recent studies have suggested that the EBV receptor is associated with the complement C3d receptor Fingeroth et al., 1984; Frade et al., 1985) . To assess the presence of the C3d receptor, the monoclonal antibody anti-CRII (Becton-Dickinson) (Frade et al., 1985) was used and tested by the indirect IF method.
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or presence (right) of TPA (10 -7 M). The unstimulated cell population is composed of numerous elements with undifferentiated cytoplasm and by cells of the monocytic lineage with a small number of granules in the cytoplasm. The proportion of the latter increases after TPA induction. * Cells (106 ceUs/ml) were grown at 37 °C for 4 days in the absence or presence of 10 -7 ra-TPA. Antibody phenotype was tested by indirect immunofluorescence and by fluorocytometry using monoclonal antibodies. Abbreviations are the names of these antibodies provided by the respective manufacturers: C, Coulter; BD, Becton Dickinson; Or, Ortho Pharmaceutical; DK, Dako. Only primary specificities are listed; shared epitopes (e.g. IL-2 receptor, B4) may be expressed on other cell subsets. Cytoplasmic antigens were detected on cytocentrifuged acetone-fixed cells.
t Results are expressed as percentage of positive cells to the nearest 5% and represent the range of values from four separate experiments run in a 6 month period.
Controls for background staining always included cells either unstained or reacted first with an irrelevant monoclonal reagent before testing the fluorescein-labelled second antibody.
EBVDNA clones. Linear EBV DNA was prepared from virus particles released by the B95-8 marmoset cell line as described (Dolyniuk et al., 1976) . Cloned EcoRI and BamHI restriction enzyme fragments of B95-8 EBV DNA (Griffin & Karran, 1984; Arrand et al., 1981) were a generous gift from Dr J. R. Arrand and Dr B. E. Griffin. The restriction map of the EcoRI and BamHI sites of EBV with a description of the clones used in this study is given in Fig. 2 . The EBV cloned fragments were radioactively labelled by nick-translation using p2p]dCTP and [32p]dATP (3000 Ci/mmol from Amersham). The specific activity of the labelled DN A was never less than 108 to 3 × l0 s c.p.m./Bg DNA.
Gelelectrophoresis and blot hybridization. DNA was extracted from fresh cell pellets consisting of at least 2 x 10 s cells (Maniatis et al., 1982) . DNA (10 p.g) was digested by EcoRI or BamHI (Bochringcr Mannheim) in excess of enzyme in a total volume of 50 gl in the buffer as described by the manufacturers, and the fragments were separated on a 0.8% agarose gel. Fragments were transferred to nitrocellulose as described by Southern (1975) , hybridized (42 °C for 20 h in 50% formamide) to nick-translated 3~p-labclled viral DNA probes and washed in highly stringent conditions (three times at room temperature in 3 x SSC with 0.1% SDS and three times at 65 °C in 0-2 x SSC with 0-1% SDS).
IP: 54.70.40.11
On: Thu, 03 Jan 2019 13:07:11 :~ Enzyme cytochemical and functional properties were analysed on cytocentrifuged cell preparations by standard procedures as previously described (Monaco et al., 1982; Sambuy et al., 1986) . § Rosette formation of the ceils was performed using neuraminidase-treated sheep erythrocytes (E). Cells with tgG Fc receptors were tested with IgG-coated sheep-E or ox-E. IgM-human complement-coated E were used for detection of C3b receptors.
EBV in non-lymphoid cell lines
II Phagocytosis of Staphylococcus aureus was performed at 37 °C for 20 min: -, + and + denote sections in which no phagocytosis, less than and more than 20% positive cells were detected, respectively.
EB Vactivity in culture supernatants. EBV release in culture supernatants was measured by human umbilical cord blood mononuclear leukocyte (CBL) immortalization, conversion of Ramos cells into EBNA-positive variants (Klein et al., 1975) and superinfection of Raji cells for EA expression (Reedman & Klein, 1973) .
RESULTS

Immune status of the donors
The immune status of the donors was consistent with previous EBV infection. Anti-VCA and anti-EA IgG were found at dilutions ranging from 1 : 10 to 1:80 in all cases. In the serum of the AD-S donor patient, low levels of anti-VCA IgM (1 : 20) and of anti-EBNA (1 : 10) were found.
EBV antigens in cell lines
Cultured cells were examined for their possible content of EBV by the IF technique using a panel of anti-EBNA-positive and anti-EBNA-negative sera at a dilution of 1:10 or greater. The results were in complete agreement with the anti-EBNA reactivities of the sera in that the positive sera stained virtually all the cells, whereas the negative sera did not. All the cells were negative after reacting with fluorescein-labelled anti-C3 antibody alone. Virtually all cells of the early passages were EBNA-positive. The proportion of EBNA-positive cells, however, decreased with time in three lines (from 100~ down to between 30 and 70~ after 1 year in culture), whereas all the CM-S ceils always remained EBNA-positive even after 300 continuous passages in culture. Untreated cells of each line did not react with reference immune sera containing antibodies against VCA and EA. However upon stimulation for 3 to 6 days with 10 -9 M-TPA, a known EBV inducer (zur Hausen et al., 1978) Arrand et al. (1981) . The radiolabelled EcoRl probes B, D and I, and the recombinant BamHI fragment p31, cloned in cosmid pH679 DNA (Griffin & Karran, 1984) , were used for hybridization.
or without TPA induction. All the cells failed to express C3d receptors, recognized by the anti-CRII monoclonal antibody. Treatment with 1 mM-to 3 raM-sodium butyrate, 5-bromo-2'-deoxyuridine (25 ~tg/ml) and dexamethasone (25 ~tg/ml) were all ineffective in inducing VCAand EA-positive cells in all four lines (data not shown).
Identification of EBV DNA
To investigate the presence and organization of EBV DNA in these cell lines, three cloned EcoRI fragments (B, D and I) (Arrand et al., 1981) and one BamHI fragment (p31) (Griffin & Karran, 1984) representing approximately 60~ of the EBV genome (Fig. 2) were hybridized to EcoRI or BamHI fragments of cellular DNA.
The fragment EcoRI B contains the BamHI fragment that codes for EBNA 1 (Summers et al., 1982; Heller et al., 1982) . The DNAs of the cell lines were digested with EcoRI and the fragments were separated on an 0-8~ agarose gel. After transferring the fragments to nitrocellulose filters, the EcoRI B fragments were visualized by hybridization with the 32p_ labelled EcoRI B probe. As shown in Fig. 3 (a) , only one fragment was found which was identical in size (28 kb) in all cell lines and was of the appropriate size for an EBV DNA fragment. The number of EBV copies present per cell in each line was estimated by comparing the signal given by a known amount of cellular DNA to scalar quantities of viral DNA. Forty EBV copies were estimated in early culture passages in lines ROV-S, CV-S and AD-S whereas approx. 20 copies were found in CM-S. In every cell line the prolonged time in culture resulted in a decrease of copy number. In CM-S, after about 200 passages, only one or two EBV copies per cell were detected. When the radiolabelled EcoRI B probe was hybridized with BamHI fragments of cell DNA, it hybridized to homologous fragments (Fig. 3b) of the same size as linear B95-8 viral DNA. Some viral genomic variations among the lines were found by comparing the size of the BamHI K bands from the hybridizations. The BamHI K fragment (5-3 kb) in ROV-S and CM-S DNA consistently showed a different size compared to the size of the same BamHI K-related fragment (4-8 kb) detected by hybridization in DNA from CV-S and AD-S cells. Variability in the size of the BamHI K fragment, which may reflect either differences among EBV isolates or heterogeneity in the IR-3 region, was previously reported by Heller et al. (1982) .
The second recombinant clone, BamHI p31 (Griffin & Karran, 1984) , contains the BamHI fragments W, L, D, T, X, I, A, b and cd (B. E. Griffin, personal communication) . For all four lines, the radiolabelled BamHI p31 probe hybridized to EcoRI fragments of the same size as those of circular EBV DNA (not shown). As expected, this probe detects BamHI A, D, I, L, T, W, X, b and cd fragments (Fig. 4 ) but in addition, detects another sequence (10 kb) which is visualized in CM-S, AD-S, ROV-S arid CV-S cell lines but is absent from B95-8 EBV. This 10 kb On: Thu, 03 Jan 2019 13:07:11 Raab-Traub et al., 1986) . Even after accepting one or another idea we can not draw any inference on the stage in the evolution of the line at which that event might have occurred.
As shown in Fig. 6 , a spectrum of EBV-related fragments were seen after hybridizing BamHI- (Fig. 6a) or EcoRI- (Fig. 6b ) digested D N A from the four cell lines with the 3Zp-labelled EcoRI I probe. Interestingly, D N A fragments from late passage CM-S cells consistently failed to hybridize this probe, suggesting the existence of a deletion. It is worth noting that the same BamHI blots, after hybridization with the radiolabelled EcoRI D probe, clearly revealed the presence of specific enzyme restriction fragments (see above).
EBV activity in culture supernatants
Immortalization assays on CBL, conversion of Ramos cells into EBV-positive variants and superinfection of Raji cells for EA expression were all attempted with cell-free supernatants collected from untreated or TPA-induced cells. All filtered (0-45 btm filters) supernatants were repeatedly found to be lacking these EBV-related biological activities in all assays performed (not shown).
DISCUSSION
We have reported here that four autonomous lines of monocyte-macrophage precursors derived from the marrow of children with maturation defects of erythropoiesis or myelopoiesis, contain Epstein-Barr viral DNA sequences. The donor individuals were serologically EBVpositive. Whereas EBV infection is not common in children younger than 3 or 4 years of age in western countries, it is not surprising that such infants and young patients repeatedly undergoing blood transfusions for maturation defects of haematopoiesis may be found seropositive. Persistent EBV infection in early childhood myeloproliferative disorders associated with non-random chromosome abnormalities has been reported (StoUman et al., 1985) . The fact that the cell lines contained EBV was demonstrated by the detection of EBNA in virtually all cells of the early passages (although the proportion of EBNA-positive cells decreased significantly with the time of culture, except for CM-S cells), and detection of EBVrelated DNA sequences by Southern blot hybridization with DNA fragments cloned from the B95-8 virus. At present the anti-EBNA reactivities detected in these cell lines have not been identified. Western immunoblotting experiments are in progress in our laboratory, to indicate which of the several possible latent nuclear antigens, or numerous lytic cycle nuclear antigens, are being expressed. As previously suggested (Ernberg et al., 1988) , possible variations of EBNAs could be useful to identify by immunoblotting different EBV isolates. Some restriction site differences allowed us to distinguish different viral genotypes among the cell lines. All the DNAs hybridized to the same probe under high stringency hybridization and wash conditions, indicating a high degree of homology among all the EBV isolates. However there are some restriction enzyme cleavage site differences in the viral genome organization. EBV is present in all cell lines in a latent state. Our efforts to transfer EBV with cell-free supernatants were always unsuccessful.
The genomic restriction pattern of EBV after long-term propagation of the cells in culture was analysed. Using cells frozen at different time intervals from the establishment of the line, we could compare EBV DNA present in cells maintained in culture for more than 3 years. The number of EBV copies per cell decreased in all lines with successive passages of the cells in culture. Our findings in CM-S cells (in which all of the cells were found always to be EBNApositive) are consistent with the idea that in a long-term culture a variant type of cells with only a persistent integrated viral copy prevails whereas in the initial cell population many EBV copies, mostly as plasmids, are present. It would be interesting to know whether viral changes in longterm culture correlate with the gradual phenotypic transformation of the cell (Sambuy et al., 1985) , the gain of non-random chromosome changes Romitti et al., 1986) , the modification of growth and differentiation properties and the acquisition and progression of tumorigenicity in vivo (Sambuy et al., 1985; Revoltella et al., 1986) . Presently, the precise role of EBV in this context is far from being assessable and might involve anything from transposon activity to specific viral gene action.
Available data do not explain whether EBV infection occurred in vivo or in vitro during an early phase of the bone marrow culture. For an explanation of the presence of EBV in these lines of monocytic phenotype, several hypotheses can be proposed. For instance it is possible to conceive that the progenitor cell from which our lines descend expressed C3d or an analogous receptor and later lost it. An alternative way of entry for the virus is hinted at by some electron microscope observations (R. P. Revoltella, unpublished results) on ultrathin sections of the culture at an early passage. Lymphocytes were observed within vacuoles in the cytoplasm of macrophage-like cells suggesting the occurrence of emperipolesis. EBV infection and immortalization of a susceptible cell in the precursor monocytic lineage or even a more primitive, pluripotent cell might have occurred after such tight cell-to-cell contacts with an EBV infected B lymphocyte. The hypothesis of somatic cell hybridization can be also proposed, as in the case of EBV-infected epithelial cells in NPC (Bayliss & Wolf, 1980) . However, the latter seems unlikely with regard to our cell lines, because the ceils retained a diploid karyotype for a prolonged time in culture from the moment of the establishment of each line . Another possibility to explain the presence of EBV in our monocytic cell lines comes from the fact that the tropism and behaviour of EBV were extensively studied for laboratory-adapted strains which might have properties rather different from those of freshly isolated virus. Sixbey et al. (1983) showed that recently isolated, and not laboratory-adapted, strains of EBV could infect human epithelial cells in vitro. The same authors similarly reported that viral genome expression was incomplete in infected cells. A similar dichotomy in the tropism and behaviour of human freshly isolated and laboratory-adapted cytomegalovirus has been reported by Einhorn & Host (1984) and Rice et al. (1984) .
Monocytes and macrophages are the source of many factors affecting all haematopoiesis. The demonstration that EBV genomes can be maintained indefinitely in human monoblasts or immature monocytic cells from bone marrow of children with maturation defects of haematopoiesis, may have implications with regards to the role of EBV in the pathogenesis of these childhood disorders in some patients.
